Use fundamental data analysis to validate all available fundamentals of Globus Medical to find out if markets are presently mispricing the organization. We found thirty-five available reported financial drivers for Globus Medical which can be compared to its competitors. To make sure the equity is not overpriced, please check out all Globus Medical fundamentals including its Price to Earning, Net Income, Book Value Per Share, as well as the relationship between Revenue and Total Debt . Given that Globus Medical has Number of Shares Shorted of 2.59M, we strongly advise you confirm Globus Medical regular market performance to make sure the company can sustain itself down the road. Use Globus Medical to protect your portfolios against small markets fluctuations. The stock experiences normal downward trend and little activity. Check odds of Globus Medical to be traded at $41.72 in 30 days.
Globus Medical Company Summary
Globus Medical competes with Digirad, Dynatronics, EDAP TMS, Electromed, and Establishment Labs. Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. Globus Medical, Inc. was founded in 2003 and is headquartered in Audubon, Pennsylvania. Globus Medical operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 1800 people.
Globus Medical Return On Asset vs Total Debt
Globus Medical is one of the top stocks in return on asset category among related companies. It is rated below average in total debt category among related companies making up about 226,636 of Total Debt per Return On Asset.
|Return On Asset ( % )|
Globus Medical Systematic Risk
Globus Medical Thematic Clasifications
Globus Medical June 24, 2019 Opportunity Range